From the RNA World to the Clinic
RNA molecules are increasingly recognized as central players in human gene regulation. This meeting focused on the intersection of basic and applied research into the mechanisms by which regulatory RNAs function. Talks and discussion covered topics including regulatory RNA structures and ribozymes, antibiotics that target the ribosome, and RNAi.
Organizers
Jennifer Doudna, HHMI/UC Berkeley
Bruce Sullenger, Duke University
Invited Participants
Daniel Anderson, Massachusetts Institute of Technology
Raul Andino, University of California, San Francisco
Ronald Breaker, HHMI/Yale University
Beverly Davidson, University of Iowa
Mark Davis, California Institute of Technology
Paloma Giangrande, University of Iowa
Joanne Kamens, RXi Pharmaceuticals
Mark Kay, Stanford University School of Medicine
Ryszard Kole, AVI BioPharma
Alan Lambowitz, University of Texas at Austin
Jeannie Lee, HHMI/Harvard University
Matthew Levy, Albert Einstein College of Medicine
Alexander Mankin, University of Illinois at Chicago
Pamela Pavco, RXi Pharmaceuticals
John Rossi, City of Hope
Alan Sachs, Merck Research Laboratories
Peter Sarnow, Stanford University
Thomas Steitz, HHMI/Yale University
James Thompson, Quark Pharmaceuticals
Gene Yeo, University of California, San Diego
Matthew Disney, University of Buffalo
Anna Pyle, Yale University
Louis Renzetti, Roche Pharmaceuticals
